Royal Bank of Canada’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3K | Sell |
1,588
-72
| -4% | -$136 | ﹤0.01% | 6333 |
|
2025
Q1 | $3K | Buy |
1,660
+675
| +69% | +$1.22K | ﹤0.01% | 6070 |
|
2024
Q4 | $3K | Buy |
985
+225
| +30% | +$685 | ﹤0.01% | 6126 |
|
2024
Q3 | $3K | Hold |
760
| – | – | ﹤0.01% | 6104 |
|
2024
Q2 | $3K | Sell |
760
-1,227
| -62% | -$4.84K | ﹤0.01% | 6242 |
|
2024
Q1 | $6K | Sell |
1,987
-11,437
| -85% | -$34.5K | ﹤0.01% | 5919 |
|
2023
Q4 | $68K | Buy |
13,424
+10,647
| +383% | +$53.9K | ﹤0.01% | 5304 |
|
2023
Q3 | $8K | Sell |
2,777
-522
| -16% | -$1.5K | ﹤0.01% | 5983 |
|
2023
Q2 | $10K | Buy |
3,299
+2,119
| +180% | +$6.42K | ﹤0.01% | 6004 |
|
2023
Q1 | $3K | Hold |
1,180
| – | – | ﹤0.01% | 6275 |
|
2022
Q4 | $2K | Buy |
1,180
+180
| +18% | +$305 | ﹤0.01% | 6431 |
|
2022
Q3 | $3K | Sell |
1,000
-3,600
| -78% | -$10.8K | ﹤0.01% | 6373 |
|
2022
Q2 | $17K | Sell |
4,600
-2,200
| -32% | -$8.13K | ﹤0.01% | 5704 |
|
2022
Q1 | $27K | Sell |
6,800
-5,859
| -46% | -$23.3K | ﹤0.01% | 5952 |
|
2021
Q4 | $62K | Sell |
12,659
-2,239
| -15% | -$11K | ﹤0.01% | 5705 |
|
2021
Q3 | $100K | Sell |
14,898
-106
| -0.7% | -$712 | ﹤0.01% | 5188 |
|
2021
Q2 | $119K | Sell |
15,004
-10,579
| -41% | -$83.9K | ﹤0.01% | 5012 |
|
2021
Q1 | $195K | Buy |
25,583
+24,673
| +2,711% | +$188K | ﹤0.01% | 4501 |
|
2020
Q4 | $4K | Buy |
910
+721
| +381% | +$3.17K | ﹤0.01% | 6158 |
|
2020
Q3 | $1K | Buy |
+189
| New | +$1K | ﹤0.01% | 5881 |
|
2019
Q4 | – | Sell |
-491
| Closed | -$2K | – | 6156 |
|
2019
Q3 | $2K | Buy |
491
+238
| +94% | +$969 | ﹤0.01% | 5601 |
|
2019
Q2 | $1K | Sell |
253
-177
| -41% | -$700 | ﹤0.01% | 5701 |
|
2019
Q1 | $2K | Buy |
+430
| New | +$2K | ﹤0.01% | 5489 |
|